Cognimark (formerly CogniScreen) is redefining the dementia care journey by building neurology assistants for clinicians. Cognimark, through our proprietary AI services and partners, aims to provide comprehensive neurology support to clinicians by 1) enabling early detection and intervention through risk-stratification in primary care, 2) providing detailed neurology and operational support at the patient visit, and 3) support appropriate next steps of care (e.g., clinical trials, therapies, neurologists).

Our proprietary algorithm ingests any combination of standard-of-care data (EHRs, neuropsychological testing, blood-based biomarkers, imaging, labs, and more) to produce detailed neurology reports focused on dementia stage and etiology. The approach is grounded in rigorous science, with peer-reviewed publications in leading journals including Nature Medicine and Brain, and Cognimark is a member of the Alzheimer’s Moonshot program supported by ADDF and Gates Ventures.


Cognimark

Org chart

Teams

Offices

Cognimark

Org chart

Teams

Offices

Related companies